{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:26:22Z","timestamp":1786112782599,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      A well-defined causal relationship between nonalcoholic fatty liver disease (NAFLD) and abdominal aortic aneurysm (AAA) is lacking, and it remains unknown whether AAA risk varies across different NAFLD stages. This study applied Mendelian randomization (MR) to evaluate the stratified effects of different NAFLD stages on AAA. Multi-omics data were integrated to identify potential mediating pathways. Large-scale genome-wide association study summary data were analyzed using inverse-variance weighted as the primary MR method. MR-Egger and weighted median MR methods were employed as complementary approaches. Sensitivity analyses were conducted using MR-PRESSO (Mendelian randomization pleiotropy residual sum and outlier), Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test, and MR-Egger testing. To further ensure the robustness of MR results, funnel plots, scatter plots and leave-one-out analyses were also constructed. Further analyses were conducted to assess the causal effects of NAFLD\/NASH on thoracic aortic aneurysm (TAA) and aortic aneurysm (AA). Multi-omics integration helped identify intermediate molecular traits. Bidirectional MR analysis demonstrated a positive causal effect of NAFLD\/NASH on AAA risk (odds ratio\u2005=\u20051.05, 95% confidence interval: 1.01\u20131.09;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.017), with no evidence for reverse causation. Validation analyses showed a reverse causal association between liver fat content and AAA, while other associations were nonsignificant. Further MR analyses revealed no significant causal effects of NAFLD\/NASH on thoracic aortic aneurysm or unclassified aortic aneurysm. Multi-omics integration identified 1 metabolite and 2 lipid species associated with NAFLD\/NASH; however, none directly caused AAA. NAFLD\/NASH exerts a positive causal effect on AAA, predominantly in advanced disease stages such as NASH and fibrosis. Multi-omics evidence suggests that certain metabolites and lipid species may serve as biomarkers or indirectly promote AAA by driving NAFLD progression, influencing AAA risk indirectly through promoting progression of NAFLD\/NASH. These findings provide genetic evidence for NAFLD-driven AAA pathogenesis, underscoring the importance of risk stratification and early intervention in advanced NAFLD.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048613","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:03:23Z","timestamp":1778745803000},"page":"e48613","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal insights into how NAFLD progression drives abdominal aortic aneurysm: A bidirectional MR study integrating genetic and multi-omics profiling"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6944-4308","authenticated-orcid":false,"given":"Rongyang","family":"Xi","sequence":"first","affiliation":[{"name":"The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4180-0936","authenticated-orcid":false,"given":"Jiuqing","family":"Yan","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9374-4505","authenticated-orcid":false,"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0414-3945","authenticated-orcid":false,"given":"Yongshun","family":"Liang","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1794-954X","authenticated-orcid":false,"given":"Siying","family":"Cai","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijingxuan","family":"Duan","sequence":"additional","affiliation":[{"name":"The First School of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260805","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejvs.2023.11.002","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms.","volume":"67","author":"Wanhainen","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R2-20260805","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/SLA.0000000000005716","article-title":"The global and regional prevalence of abdominal aortic aneurysms: a systematic review and modeling analysis.","volume":"277","author":"Song","year":"2023","journal-title":"Ann Surg"},{"key":"R3-20260805","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"suppl","key":"R4-20260805","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes.","volume":"29","author":"Han","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R5-20260805","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12933-024-02434-5","article-title":"Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review.","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"R6-20260805","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/AnatolJCardiol.2021.433","article-title":"Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men.","volume":"26","author":"Sarikaya","year":"2022","journal-title":"Anatol J Cardiol"},{"key":"R7-20260805","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12880-025-01559-7","article-title":"Association between non-alcoholic fatty liver disease and progression of abdominal aortic aneurysm: a multicenter study.","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Med Imaging"},{"key":"R8-20260805","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options.","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R9-20260805","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMcp2108504","article-title":"Management of abdominal aortic aneurysms.","volume":"385","author":"Schanzer","year":"2021","journal-title":"N Engl J Med"},{"key":"R10-20260805","first-page":"44","article-title":"Causal associations between the gut microbiome and aortic aneurysm: a Mendelian randomization study.","volume":"9","author":"Lv","year":"2024","journal-title":"Cardiovasc Innov Appl"},{"key":"R11-20260805","first-page":"25","article-title":"Rheumatoid arthritis and risk of atrial fibrillation: results from pooled cohort studies and Mendelian randomization analysis.","volume":"9","author":"Song","year":"2024","journal-title":"Cardiovasc Innov Appl"},{"key":"R12-20260805","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41588-023-01518-4","article-title":"Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification.","volume":"55","author":"Kavousi","year":"2023","journal-title":"Nat Genet"},{"key":"R13-20260805","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2020.04.003","article-title":"Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort(\u2606).","volume":"73","author":"Anstee","year":"2020","journal-title":"J Hepatol"},{"key":"R14-20260805","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.xgen.2022.100192","article-title":"Global Biobank meta-analysis initiative: powering genetic discovery across human disease.","volume":"2","author":"Zhou","year":"2022","journal-title":"Cell Genom"},{"key":"R15-20260805","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/s42003-022-04237-4","article-title":"The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition.","volume":"5","author":"van der Meer","year":"2022","journal-title":"Commun Biol"},{"key":"R16-20260805","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease.","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"R17-20260805","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R18-20260805","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations.","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"R19-20260805","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-024-07148-y","article-title":"Genome-wide characterization of circulating metabolic biomarkers.","volume":"628","author":"Karjalainen","year":"2024","journal-title":"Nature"},{"key":"R20-20260805","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.32534","article-title":"Relationship between NAFLD and coronary artery disease: a Mendelian randomization study.","volume":"77","author":"Ren","year":"2023","journal-title":"Hepatology"},{"key":"R21-20260805","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gepi.22522","article-title":"Bias correction for inverse variance weighting Mendelian randomization.","volume":"47","author":"Mounier","year":"2023","journal-title":"Genet Epidemiol"},{"key":"R22-20260805","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R23-20260805","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction.","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol Opt"},{"key":"R24-20260805","doi-asserted-by":"crossref","first-page":"155220","DOI":"10.1016\/j.metabol.2022.155220","article-title":"Nonalcoholic fatty liver disease and cardiovascular diseases: a Mendelian randomization study.","volume":"133","author":"Peng","year":"2022","journal-title":"Metabolism"},{"key":"R25-20260805","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.molcel.2025.02.022","article-title":"beta-hydroxybutyrate facilitates mitochondrial-derived vesicle biogenesis and improves mitochondrial functions.","volume":"85","author":"Tang","year":"2025","journal-title":"Mol Cell"},{"key":"R26-20260805","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41467-024-49921-7","article-title":"Abdominal aortic aneurysm and cardiometabolic traits share strong genetic susceptibility to lipid metabolism and inflammation.","volume":"15","author":"Zheng","year":"2024","journal-title":"Nat Commun"},{"key":"R27-20260805","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/apt.15660","article-title":"Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.","volume":"51","author":"Henson","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-20260805","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.numecd.2023.11.004","article-title":"Association between metabolic dysfunction-associated fatty liver disease and abdominal aortic aneurysm.","volume":"34","author":"Jia","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R29-20260805","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2147\/DMSO.S205568","article-title":"The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study.","volume":"12","author":"Mahamid","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R30-20260805","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.3390\/ijms241310777","article-title":"Effects of miR-33 deficiency on metabolic and cardiovascular diseases: implications for therapeutic intervention.","volume":"24","author":"Ortega","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R31-20260805","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00109-025-02524-1","article-title":"Lipidomic insights on abdominal aortic aneurysm and peripheral arterial disease.","volume":"103","author":"Ferreira","year":"2025","journal-title":"J Mol Med (Berl)"},{"key":"R32-20260805","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/metabo11080555","article-title":"Metabolomic profile of abdominal aortic aneurysm.","volume":"11","author":"Lieberg","year":"2021","journal-title":"Metabolites"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T16:02:01Z","timestamp":1785945721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":32,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048613","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"2025-11-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}